2024
Clopidogrel-Mediated P2Y12 Inhibition According to Renal Function in Patients With Diabetes Mellitus and CAD.
JACC. Basic to translational science
鈥�Research at a glance
Top areas of exploration
- Platelet Aggregation Inhibitors , 14 publications
- Clopidogrel , 11 publications
- Ticagrelor , 10 publications
- Platelet Aggregation , 8 publications
Research activity
My publications
Filter publications
33 publications
2024
P2Y12 Inhibition in Patients Requiring Oral聽Anticoagulation After Percutaneous聽Coronary Intervention: The SWAP-AC-2 Study.
JACC. Cardiovascular interventions
鈥�2024
Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study.
Thrombosis and haemostasis
鈥�2023
Cangrelor in Patients With Coronary Artery Disease Pretreated With聽Ticagrelor: The Switching Antiplatelet (SWAP)-5 Study.
JACC. Cardiovascular interventions
鈥�2023
Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-controlled study.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
鈥�